Easier diagnosis of esophageal cancer

March 6, 2017, Helmholtz Association of German Research Centres
New imaging technologies allow earlier diagnosis of tumors. Credit: Source: Murad Omar/Helmholtz Zentrum München

The Institute of Biological and Medical Imaging at Helmholtz Zentrum München is heading the "Hybrid optical and optoacoustic endoscope for esophageal tracking" (ESOTRAC) research project, in which engineers and physicians together develop a novel hybrid endoscopic instrument for early diagnosis and staging of esophageal cancer. The device may reduce the number of unnecessary biopsies and, importantly, facilitate early-disease detection leading to earlier start of therapy, which improves therapeutic efficacy over late-disease treatment and leads to immense cost-savings for the health care system. ESOTRAC has been awarded four million Euros from Horizon 2020, the EU framework program for research and innovation.

With more than 450 000 new cases per year and a five-year survival rate of only ten percent when diagnosed late, (EC) is the sixth-leading cause of cancer-related deaths. Currently EC is detected using white-light endoscopy or random tissue biopsies, followed by histopathological analysis of excised tissue. Due to limitations of the current detection methods, EC is typically detected at an advanced stage which is treated surgically and attains poor survival prognosis.

ESOTRAC, a 4-year research program bringing together engineers and physicians, aims to significantly improve the detection of early-stage EC. The interdisciplinary, 5-country research team will develop an innovative endoscope that combines sensing of pathophysiological tissue signatures resolved by multi-spectral optoacoustic (photoacoustic) tomography (MSOT) with morphological disease signatures provided by optical coherence tomography (OCT). The resulting system will operate in label free mode and, due to its tomographic ability, visualize sub-surface tissue features, providing superior information of the esophageal wall compared to conventional video endoscopes. This comprehensive sub-surface information is expected to detect early-stage EC and enable disease staging, neither of which can be done reliably today. The novel endoscope can be further useful in reducing the number of unnecessary biopsies by providing more accurate guidance to suspicious areas over white-light endoscopy.

Raising the bar for endoscopic care - and beyond

The device developed by ESOTRAC promises to change the landscape of gastroenterological endoscopy - beyond diagnosis of EC - by allowing rapid three-dimensional imaging of the entire esophageal wall as well as quantitation of disease biomarkers. "The combination of MSOT and OCT can shape the way physicians look at the esophagus in the near future," said Prof. Vasilis Ntziachristos, ESOTRAC Coordinator, Director of the Institute of Biological and Medical Imaging at Helmholtz Zentrum München and Professor and Chair of Biological Imaging at the Technical University of Munich. "From a clinical perspective we desperately need new technologies that improve imaging and combine information on molecular markers for early detection of disease and this research is trying to do exactly that" said Prof. Rebecca Fitzgerald, a world-leading clinical expert in esophageal cancer and lead physician at the MRC Cancer Unit at the Cambridge Biomedical Campus in the UK, one of the ESOTRAC partners.

Since one of the goals of ESOTRAC is to offer quantitative metrics of EC disease, toward personalized and precision medicine, the device may help equalize the quality of endoscopy-based care in rural and urban settings. The ESOTRAC endoscope will also be built to be as small and patient-friendly as possible, reducing the risk of gag reflex and therefore the need for sedation. In these ways, ESOTRAC aims to create an endoscope that can be widely deployed in gastroenterology clinics. At the same time, the lessons learned in building the ESOTRAC endoscope may help guide the design of next-generation imaging devices for the other body cavities, including the colon.

Explore further: Study shows in vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia

Related Stories

Study shows in vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia

February 19, 2014
New research shows that the addition of confocal laser endomicroscopy to high-definition white-light endoscopy enables improved real-time endoscopic diagnosis of Barrett's esophagus dysplasia (neoplastic tissue) by using ...

Life expectancy prolonged for esophageal cancer patients

June 4, 2012
For those with esophageal cancer, initial staging of the disease is of particular importance as it determines whether to opt for a curative treatment or palliative treatment. Research presented in the June issue of The Journal ...

Study: Microendoscope could eliminate unneeded biopsies

June 2, 2015
In a clinical study of patients in the United States and China, researchers found that a low-cost, portable, battery-powered microendoscope developed by Rice University bioengineers could eventually eliminate the need for ...

Study shows long-term efficacy of minimally invasive therapy for patients with Barrett's esophagus

February 20, 2013
According to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, patients with Barrett's esophagus and early or pre-cancerous cells have been shown to significantly benefit from ...

Presence of certain oral bacterium in esophageal cancer samples associated with shorter survival

October 21, 2016
Bottom Line: Among Japanese patients with esophageal cancer, those whose cancer tested positive for DNA from the bacterium Fusobacterium nucleatum had shorter cancer-specific survival compared with those whose cancer had ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

Overcoming resistance to a standard chemotherapy drug

July 19, 2018
Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

crystaljtoller
not rated yet Mar 07, 2017
Esophageal cancer symptoms involve a tumor or malignant injury in the muscular tube that connects the back of the throat to the stomach. Esophageal cancer is rare among the younger population, and it generally strikes people over the age of fifty. Diagnosis of esophageal cancer is easier as layer has a distinct function and knowing which layer is involved in the cancer during diagnosis is the key to understanding how aggressive the cancer is. One can more information here advancedradiationcenters.com, about the treatment of various cancers.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.